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Brain dysmorphology is one of the most critical features of Fetal Alcohol Spectrum Disorders 
(FASD). This study was designed to use high resolution preclinical MRI system to compare the 
brain structures between alcohol exposed C57BL/6 mice with control. The objective is to 
examine how alcohol affects a dose- and timing-dependent brain dysmorphology during 
development comparable to that of human FASD. Three treated groups, ALC (pre- and 
pregnancy alcohol with 4.2 % (v/v) alcohol liquid), PF (pre alcohol and a calorically matched 
liquid pregnancy diet), and CHOW (ad lib chow/water), were examined. Mouse heads were 
imaged using 9.4T preclinical MRI system with 3D gradient echo (GRE) sequence to acquire 
volumetric images with voxel size as low as 40 microns. Whole brain, olfactory bulbs, cortex, 
hypothalamus, and cerebellum were segmented and the volumes were calculated. Data was 
examined by ANOVA followed with paired comparison between treatment groups to test the 
effect of prenatal alcohol exposure.  ALC group had shown consistently smaller mean volumes 
of difference brain regions than the other two groups. Volume of total brain, olfactory bulbs and 
cerebellum were observed to be significantly different for ALC compared to PF pups. This 
indicated that prenatal alcohol exposure caused retarded fetal brain development. Comparing 
PF with CHOW pups, only cerebellum volume was observed to be significantly different. For 
cortex volume, no significant difference was shown for any pairwise comparison. These results 
suggest that alcohol effect contribute to brain dysmorphology, and match with our previous 
craniofacial dysmorphology study. This could be important to assist in the understanding of 
clinical variants of human FASD patients in brain dysmorphology. 
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